Completed PHASE4 INTERVENTIONAL 2-arm NCT01303627

Safety of Remifentanil Infusion

The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality

Sponsor: Diskapi Teaching and Research Hospital

Updated 9 times since 2017 Last updated: Jun 15, 2012 Started: Feb 28, 2011 Primary completion: Mar 31, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Urinary Tract Problem, this trial is completed. The trial is conducted by Diskapi Teaching and Research Hospital and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Sep 2020 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Sep 2020 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diskapi Teaching and Research Hospital

Data source: Diskapi Teaching and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)